These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 19513295)

  • 1. Use of the Putamen/Caudate Volume Ratio for Early Differentiation between Parkinsonian Variant of Multiple System Atrophy and Parkinson Disease.
    Shin HY; Kang SY; Yang JH; Kim HS; Lee MS; Sohn YH
    J Clin Neurol; 2007 Jun; 3(2):79-81. PubMed ID: 19513295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The putaminal abnormalities on 3.0T magnetic resonance imaging: can they separate parkinsonism-predominant multiple system atrophy from Parkinson's disease?
    Feng JY; Huang B; Yang WQ; Zhang YH; Wang LM; Wang LJ; Zhong XL
    Acta Radiol; 2015 Mar; 56(3):322-8. PubMed ID: 24619850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphometric MRI profiles of multiple system atrophy variants and implications for differential diagnosis.
    Krismer F; Seppi K; Göbel G; Steiger R; Zucal I; Boesch S; Gizewski ER; Wenning GK; Poewe W; Scherfler C
    Mov Disord; 2019 Jul; 34(7):1041-1048. PubMed ID: 30919495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multimodal MRI assessment of nigro-striatal pathway in multiple system atrophy and Parkinson disease.
    Barbagallo G; Sierra-Peña M; Nemmi F; Traon AP; Meissner WG; Rascol O; Péran P
    Mov Disord; 2016 Mar; 31(3):325-34. PubMed ID: 26676922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiating between multiple system atrophy and Parkinson's disease by positron emission tomography with 18F-dopa and 18F-FDG.
    Otsuka M; Kuwabara Y; Ichiya Y; Hosokawa S; Sasaki M; Yoshida T; Fukumura T; Kato M; Masuda K
    Ann Nucl Med; 1997 Aug; 11(3):251-7. PubMed ID: 9310175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffusion-weighted MRI differentiates the Parkinson variant of multiple system atrophy from PD.
    Schocke MF; Seppi K; Esterhammer R; Kremser C; Jaschke W; Poewe W; Wenning GK
    Neurology; 2002 Feb; 58(4):575-80. PubMed ID: 11865135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progression of putaminal degeneration in multiple system atrophy: a serial diffusion MR study.
    Seppi K; Schocke MF; Mair KJ; Esterhammer R; Scherfler C; Geser F; Kremser C; Boesch S; Jaschke W; Poewe W; Wenning GK
    Neuroimage; 2006 May; 31(1):240-5. PubMed ID: 16443375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating posterolateral linearization of the putaminal margin with magnetic resonance imaging to diagnose the Parkinson variant of multiple system atrophy.
    Ito S; Shirai W; Hattori T
    Mov Disord; 2007 Mar; 22(4):578-81. PubMed ID: 17260343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of 3D-PRESTO imaging in evaluating putaminal abnormality in parkinsonian variant of multiple system atrophy.
    Sakurai K; Kawaguchi T; Kawai T; Ogino H; Hara M; Okita K; Yamawaki T; Shibamoto Y
    Neuroradiology; 2010 Sep; 52(9):809-14. PubMed ID: 19894040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 99mTc-TRODAT-1 imaging of multiple system atrophy.
    Lu CS; Weng YH; Chen MC; Chen RS; Tzen KY; Wey SP; Ting G; Chang HC; Yen TC
    J Nucl Med; 2004 Jan; 45(1):49-55. PubMed ID: 14734673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic value of brain MRI and 18F-FDG PET in the differentiation of Parkinsonian-type multiple system atrophy from Parkinson's disease.
    Kwon KY; Choi CG; Kim JS; Lee MC; Chung SJ
    Eur J Neurol; 2008 Oct; 15(10):1043-9. PubMed ID: 18717730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Putaminal hyperintensity on T1-weighted MR imaging in patients with the Parkinson variant of multiple system atrophy.
    Ito S; Shirai W; Hattori T
    AJNR Am J Neuroradiol; 2009 Apr; 30(4):689-92. PubMed ID: 19147717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subregional patterns of preferential striatal dopamine transporter loss differ in Parkinson disease, progressive supranuclear palsy, and multiple-system atrophy.
    Oh M; Kim JS; Kim JY; Shin KH; Park SH; Kim HO; Moon DH; Oh SJ; Chung SJ; Lee CS
    J Nucl Med; 2012 Mar; 53(3):399-406. PubMed ID: 22323779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between locomotor disability, autonomic dysfunction, and the integrity of the striatal dopaminergic system in patients with multiple system atrophy, pure autonomic failure, and Parkinson's disease, studied with PET.
    Brooks DJ; Salmon EP; Mathias CJ; Quinn N; Leenders KL; Bannister R; Marsden CD; Frackowiak RS
    Brain; 1990 Oct; 113 ( Pt 5)():1539-52. PubMed ID: 2123119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Voxelwise meta-analysis of gray matter anomalies in Parkinson variant of multiple system atrophy and Parkinson's disease using anatomic likelihood estimation.
    Shao N; Yang J; Shang H
    Neurosci Lett; 2015 Feb; 587():79-86. PubMed ID: 25484255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of putaminal diffusion imaging versus 18-fluorodeoxyglucose positron emission tomography for the differential diagnosis of the Parkinson variant of multiple system atrophy.
    Baudrexel S; Seifried C; Penndorf B; Klein JC; Middendorp M; Steinmetz H; Grünwald F; Hilker R
    Mov Disord; 2014 Mar; 29(3):380-7. PubMed ID: 24243813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Putaminal hypointensity in the parkinsonian variant of multiple system atrophy: simple visual assessment using susceptibility-weighted imaging.
    Lee JH; Baik SK
    J Mov Disord; 2011 Oct; 4(2):60-3. PubMed ID: 24868396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Volume of Interest Analysis of Spatially Normalized PRESTO Imaging to Differentiate between Parkinson Disease and Atypical Parkinsonian Syndrome.
    Sakurai K; Imabayashi E; Tokumaru AM; Ito K; Shimoji K; Nakagawa M; Ozawa Y; Shimohira M; Ogawa M; Morimoto S; Aiba I; Matsukawa N; Shibamoto Y
    Magn Reson Med Sci; 2017 Jan; 16(1):16-22. PubMed ID: 27001391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of susceptibility-weighted MRI in differentiating Parkinson's disease and atypical parkinsonism.
    Gupta D; Saini J; Kesavadas C; Sarma PS; Kishore A
    Neuroradiology; 2010 Dec; 52(12):1087-94. PubMed ID: 20358367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The "Black Straight-Line Sign" in the Putamen in Diffusion-Weighted Imaging: A Potential Diagnostic MRI Marker for Multiple System Atrophy.
    Zheng Y; Wang X; Zhao H; Jiang Y; Zhu Y; Chen J; Sun W; Wang Z; Sun Y
    Front Neurol; 2022; 13():890168. PubMed ID: 35665040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.